The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.

The level of efficacy seen in AReSVi-006 also means that the bar has been set high for GSK's competitors in the category, which include Pfizer, Johnson & Johnson, Bavarian Nordic, and Moderna.

Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by the end of the decade, a sharp ...